ELI LILLY & CO (LLY)
Clinical trial NCT06085144 updates: 1. completion date: 2026-04-01 → 2028-04-01 2. primary completion date: 2026-04-01 → 2028-04-01
Clinical trial NCT06085144 updates: 1. completion date: 2026-04-01 → 2028-04-01 2. primary completion date: 2026-04-01 → 2028-04-01
📉 **NEGATIVE** • Medium confidence analysis (61%) • Mild negative clinical indicator • Limited downside risk **Sentiment:** Negative (25%) **Content type:** Clinical